FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101874359> ?p ?o ?g. }

• W2101874359 endingPage "68" @default.
• W2101874359 startingPage "63" @default.
• W2101874359 abstract "To assess the effect of ceftazidime resistance on the activity of other antimicrobial agents, 3030 ceftazidime-resistant Gram-negative bacilli (GNB) isolates (of a total of 42061 GNB) were tested against a panel of more than 30 agents. Ceftazidime resistance was observed in 40.3% of Acinetobacter spp., 16.9% of Pseudomonas aeruginosa, and 5.7% of Enterobacteriaceae isolates. The highest rates of ceftazidime resistance among the enteric GNB were observed with Enterobacter spp. (20.9%) >Citrobacter spp. (15.3%) > indole-positive Proteae (10.1%). Overall, 90% of ceftazidime-resistant Enterobacteriaceae and 30% of ceftazidime-resistant P. aeruginosa remained susceptible to the 4th-generation cephalosporin, cefepime. The activities (% susceptible) of other antimicrobials tested against ceftazidime-resistant Enterobacteriaceae and P. aeruginosa, respectively, were as follows: amikacin, 90% and 88%; ciprofloxacin, 63% and 46%; gentamicin, 59% and 67%, imipenem, 99% and 65%; levofloxacin, 69% and 44%; and piperacillin/tazobactam only 40% and 12%. Ceftazidime-resistant GNB exhibited high rates of resistance to other antimicrobials. Cefepime was very active against ceftazidime-resistant enteric GNB (AmpC enzyme producers), especially Enterobacter spp. (94.3% susceptible), Citrobacter spp. (96.7% susceptible), and indole-positive Proteae (89.6% susceptible), and showed activity similar to that of ceftazidime against all P. aeruginosa and Acinetobacter spp. isolated in North American medical centers. Continued resistances surveillance monitoring will be necessary to assess the effectiveness of widely used broad-spectrum antimicrobials as novel resistance mechanisms emerge." @default.
• W2101874359 created "2016-06-24" @default.
• W2101874359 creator A5018102677 @default.
• W2101874359 creator A5044679653 @default.
• W2101874359 creator A5060213487 @default.
• W2101874359 creator A5089371529 @default.
• W2101874359 date "2006-09-01" @default.
• W2101874359 modified "2023-10-03" @default.
• W2101874359 title "Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)" @default.
• W2101874359 cites W130264434 @default.
• W2101874359 cites W1925363657 @default.
• W2101874359 cites W2004887795 @default.
• W2101874359 cites W2039563221 @default.
• W2101874359 cites W2043819194 @default.
• W2101874359 cites W2088736329 @default.
• W2101874359 cites W2097548272 @default.
• W2101874359 cites W2098526726 @default.
• W2101874359 cites W2099264750 @default.
• W2101874359 cites W2100619231 @default.
• W2101874359 cites W2107071820 @default.
• W2101874359 cites W2109481306 @default.
• W2101874359 cites W2118939119 @default.
• W2101874359 cites W2121789287 @default.
• W2101874359 cites W2131443556 @default.
• W2101874359 cites W2131525143 @default.
• W2101874359 cites W2144931844 @default.
• W2101874359 cites W2148706534 @default.
• W2101874359 cites W2153868993 @default.
• W2101874359 cites W2156631857 @default.
• W2101874359 cites W2170605303 @default.
• W2101874359 doi "https://doi.org/10.1016/j.diagmicrobio.2006.02.009" @default.
• W2101874359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16650951" @default.
• W2101874359 hasPublicationYear "2006" @default.
• W2101874359 type Work @default.
• W2101874359 sameAs 2101874359 @default.
• W2101874359 citedByCount "31" @default.
• W2101874359 countsByYear W21018743592012 @default.
• W2101874359 countsByYear W21018743592013 @default.
• W2101874359 countsByYear W21018743592014 @default.
• W2101874359 countsByYear W21018743592015 @default.
• W2101874359 countsByYear W21018743592016 @default.
• W2101874359 countsByYear W21018743592017 @default.
• W2101874359 countsByYear W21018743592018 @default.
• W2101874359 countsByYear W21018743592020 @default.
• W2101874359 countsByYear W21018743592023 @default.
• W2101874359 crossrefType "journal-article" @default.
• W2101874359 hasAuthorship W2101874359A5018102677 @default.
• W2101874359 hasAuthorship W2101874359A5044679653 @default.
• W2101874359 hasAuthorship W2101874359A5060213487 @default.
• W2101874359 hasAuthorship W2101874359A5089371529 @default.
• W2101874359 hasConcept C104317684 @default.
• W2101874359 hasConcept C2775945818 @default.
• W2101874359 hasConcept C2776968632 @default.
• W2101874359 hasConcept C2777050379 @default.
• W2101874359 hasConcept C2777637488 @default.
• W2101874359 hasConcept C2778193466 @default.
• W2101874359 hasConcept C2778266534 @default.
• W2101874359 hasConcept C2778512257 @default.
• W2101874359 hasConcept C2778523567 @default.
• W2101874359 hasConcept C2778983983 @default.
• W2101874359 hasConcept C2779631663 @default.
• W2101874359 hasConcept C4937899 @default.
• W2101874359 hasConcept C501593827 @default.
• W2101874359 hasConcept C523546767 @default.
• W2101874359 hasConcept C54355233 @default.
• W2101874359 hasConcept C547475151 @default.
• W2101874359 hasConcept C55493867 @default.
• W2101874359 hasConcept C71924100 @default.
• W2101874359 hasConcept C86803240 @default.
• W2101874359 hasConcept C89423630 @default.
• W2101874359 hasConcept C94665300 @default.
• W2101874359 hasConceptScore W2101874359C104317684 @default.
• W2101874359 hasConceptScore W2101874359C2775945818 @default.
• W2101874359 hasConceptScore W2101874359C2776968632 @default.
• W2101874359 hasConceptScore W2101874359C2777050379 @default.
• W2101874359 hasConceptScore W2101874359C2777637488 @default.
• W2101874359 hasConceptScore W2101874359C2778193466 @default.
• W2101874359 hasConceptScore W2101874359C2778266534 @default.
• W2101874359 hasConceptScore W2101874359C2778512257 @default.
• W2101874359 hasConceptScore W2101874359C2778523567 @default.
• W2101874359 hasConceptScore W2101874359C2778983983 @default.
• W2101874359 hasConceptScore W2101874359C2779631663 @default.
• W2101874359 hasConceptScore W2101874359C4937899 @default.
• W2101874359 hasConceptScore W2101874359C501593827 @default.
• W2101874359 hasConceptScore W2101874359C523546767 @default.
• W2101874359 hasConceptScore W2101874359C54355233 @default.
• W2101874359 hasConceptScore W2101874359C547475151 @default.
• W2101874359 hasConceptScore W2101874359C55493867 @default.
• W2101874359 hasConceptScore W2101874359C71924100 @default.
• W2101874359 hasConceptScore W2101874359C86803240 @default.
• W2101874359 hasConceptScore W2101874359C89423630 @default.
• W2101874359 hasConceptScore W2101874359C94665300 @default.
• W2101874359 hasIssue "1" @default.
• W2101874359 hasLocation W21018743591 @default.
• W2101874359 hasLocation W21018743592 @default.
• W2101874359 hasOpenAccess W2101874359 @default.
• W2101874359 hasPrimaryLocation W21018743591 @default.
• W2101874359 hasRelatedWork W1955870532 @default.

• next